Two-year imaging outcomes from a phase 3 randomized trial of secukinumab in patients with non-radiographic axial spondyloarthritis

BACKGROUND: Radiographic progression and course of inflammation over 2 years in patients with non-radiographic axial spondyloarthritis (nr-axSpA) from the phase 3, randomized, PREVENT study are reported here. METHODS: In the PREVENT study, adult patients fulfilling the Assessment of SpondyloArthriti...

Descripción completa

Detalles Bibliográficos
Autores principales: Braun, Juergen, Blanco, Ricardo, Marzo-Ortega, Helena, Gensler, Lianne S., Van den Bosch, Filip, Hall, Stephen, Kameda, Hideto, Poddubnyy, Denis, van de Sande, Marleen, van der Heijde, Désirée, Zhuang, Tingting, Stefanska, Anna, Readie, Aimee, Richards, Hanno B., Deodhar, Atul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186767/
https://www.ncbi.nlm.nih.gov/pubmed/37194094
http://dx.doi.org/10.1186/s13075-023-03051-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186767/
https://www.ncbi.nlm.nih.gov/pubmed/37194094
http://dx.doi.org/10.1186/s13075-023-03051-5

Ejemplares similares